Point72 Hong Kong’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,517
Closed -$8K 2544
2022
Q1
$8K Buy
+2,517
New +$7.92K ﹤0.01% 1637
2021
Q4
Sell
-610
Closed -$2K 2549
2021
Q3
$2K Sell
610
-1,016
-62% -$4K ﹤0.01% 1888
2021
Q2
$7K Buy
+1,626
New +$7.21K ﹤0.01% 1777
2021
Q1
Sell
-9,868
Closed -$57K 2336
2020
Q4
$57K Buy
+9,868
New +$74.7K ﹤0.01% 1196
2020
Q3
Sell
-10,402
Closed -$36K 1615
2020
Q2
$36K Buy
10,402
+9,513
+1,070% +$27.5K ﹤0.01% 792
2020
Q1
$1K Sell
889
-1,472
-62% -$2.47K ﹤0.01% 885
2019
Q4
$5K Buy
2,361
+2,093
+781% +$7.86K ﹤0.01% 1044
2019
Q3
$1K Buy
+268
New +$1.62K ﹤0.01% 929
2018
Q3
Sell
-3,835
Closed -$51K 1247
2018
Q2
$51K Buy
+3,835
New +$48K 0.02% 426

Other funds holding CBAY